BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance ...

VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused

Related Keywords

United Kingdom ,Vancouver ,British Columbia ,Canada ,British ,Betterlife Pharma ,Steven Sangha ,David Melles ,Ahmad Doroudian ,Betterlife Pharma Inc ,Qlife Pharma ,Convertible Debentures ,Chief Executive Officer ,Multilateral Instrument ,Investor Relations ,Region ,